For research use only. Not for therapeutic Use.
USP15-IN-1 is a potent USP15 inhibitor with an IC50 value of 3.76 μM. USP15-IN-1 can be used for researching anticancer[1].
USP15-IN-1 (compound IM001) (0.001-5 μM; 48 h) exhibits highly anti-proliferative activity against non-small cell lung carcinoma and leukemia cells[1].
| Catalog Number | I042909 |
| CAS Number | 2260826-16-0 |
| Synonyms | N-(2-hydroxyethyl)-2-(2-phenylacetyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-6-carboxamide |
| Molecular Formula | C22H23N3O3 |
| Purity | ≥95% |
| InChI | InChI=1S/C22H23N3O3/c26-11-9-23-22(28)16-6-7-19-18(13-16)17-8-10-25(14-20(17)24-19)21(27)12-15-4-2-1-3-5-15/h1-7,13,24,26H,8-12,14H2,(H,23,28) |
| InChIKey | GVWIQMYLHREBIR-UHFFFAOYSA-N |
| SMILES | C1CN(CC2=C1C3=C(N2)C=CC(=C3)C(=O)NCCO)C(=O)CC4=CC=CC=C4 |
| Reference | [1]. Chen Yihua, et al. The tetrahydro-beta-carboline micromolecular organic compound and its derivative and medical usage of a kind of hydroxyl substitution. CN108727370A |
